Literature DB >> 1737354

Circadian variation of tumor blood flow in rat subcutaneous tumors and its alteration by angiotensin II-induced hypertension.

K Hori1, M Suzuki, S Tanda, S Saito, M Shinozaki, Q H Zhang.   

Abstract

Circadian fluctuation in tumor blood flow of the rat subcutaneous tumor was investigated. Tumor tissue blood flows in the daytime zone (10 a.m. to 4 p.m.) and in the nighttime zone (10 p.m. to 4 a.m.) in both the first phase (doubling time of tumor volume = 1.7 days) and the second phase (doubling time of tumor volume = 5.7 days) of growth of the LY80 tumor in rats were measured using the hydrogen gas clearance technique. In the first phase of tumor growth, the tumor blood flow was 20.3 +/- 12.2 ml/min/100 g in the daytime zone (n = 22) and 46.6 +/- 19.3 ml/min/100 g in the nighttime zone (n = 22). In the second phase, tumor blood flow was 9.6 +/- 5.7 ml/min/100 g in the daytime zone (n = 45) and 19.4 +/- 8.2 ml/min/100 g in the nighttime zone (n = 38). Tumor blood flow in the nighttime zone was significantly higher than that in the daytime zone (first phase, P less than 0.001; second phase, P less than 0.001). However, there were no significant differences in the mean arterial blood pressure, tumor size, and body weight of rats between the daytime zone and the nighttime zone. There was also a marked difference in the effect of angiotensin II-induced hypertension on tumor blood flow between the daytime zone and the nighttime zone. These results suggest that circadian fluctuations in tumor blood flow should be carefully considered when developing strategies to maximize the effectiveness of cancer therapy in relation to the flow rate of circulating blood.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737354

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Blood flow influences vascular growth during tumour angiogenesis.

Authors:  R Nasu; H Kimura; K Akagi; T Murata; Y Tanaka
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

2.  A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors.

Authors:  Y Nihei; Y Suga; Y Morinaga; K Ohishi; A Okano; K Ohsumi; T Hatanaka; R Nakagawa; T Tsuji; Y Akiyama; S Saito; K Hori; Y Sato; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1999-09

3.  Antitumor effects due to irreversible stoppage of tumor tissue blood flow: evaluation of a novel combretastatin A-4 derivative, AC7700.

Authors:  K Hori; S Saito; Y Nihei; M Suzuki; Y Sato
Journal:  Jpn J Cancer Res       Date:  1999-09

4.  Circadian dynamics of tumor necrosis factor alpha (cachectin) lethality.

Authors:  W J Hrushesky; T Langevin; Y J Kim; P A Wood
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

5.  Variation of growth rate of a rat tumour during a light-dark cycle: correlation with circadian fluctuations in tumour blood flow.

Authors:  K Hori; Q H Zhang; H C Li; S Saito
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

6.  Effects of intravenous infusion of dopamine on tumor blood flow in rat subcutis.

Authors:  S Tanda; K Hori; S Saito; Q H Zhang; H C Li; M Suzuki
Journal:  Jpn J Cancer Res       Date:  1994-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.